Key facts
- Jeffrey L. Gendell filed SCHEDULE 13G/A for Avadel Pharmaceuticals plc American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Tontine Asset Associates, LLC | 2.9% | 2,859,475 | 0 | 2,859,475 | Jeffrey L. Gendell | Managing Member | |
| Tontine Capital Overseas Master Fund II, L.P. | 2.9% | 2,859,475 | 0 | 2,859,475 | Jeffrey L. Gendell | Managing Member of Tontine Asset Associates, LLC, the general partner of Tontine Capital Overseas Master Fund II, L.P. | |
| Jeffrey L. Gendell | 4.9% | 4,839,357 | 70,000 | 4,769,357 | Jeffrey L. Gendell | Jeffrey L. Gendell |
CIK / CUSIP context first